Luncheon with the Experts: Thomas Hope, MD
Thomas Hope, MD, https://profiles.ucsf.edu/thomas.hope, Director of Molecular Therapy in the Department of Radiology and Biomedical Imaging at the University of California, San Francisco, and Chief of Nuclear Medicine at the San Francisco VA Medical Center, was the featured guest for Luncheon with the Experts on January 20, 2022. Dr. Hope’s main research focus is on novel imaging agents and therapies, particularly in neuroendocrine tumors and prostate cancer. He led the development of Ga-68 PSMA-11, which subsequently led to the approval of this drug by the FDA. He has combined his interest in MR imaging with PET in the simultaneous modality PET/MRI, helping lead the development of the clinical PET/MRI program. Dr. Hope also leads the PRRT (peptide receptor radionuclide therapy) program for neuroendocrine tumors and PSMA Radioligand Therapy at UCSF. An international leader in PET/MR research and the translation of new molecular imaging agents, Dr. Hope launched the highly successful PSMA prostate program at UCSF and championed the use of multiple new targeted therapies to treat patients with neuroendocrine and other tumors. He currently serves as principal investigator on grants from the NIH and the Prostate Cancer Foundation. Dr. Hope is the recipient of numerous honors in molecular imaging, including the Henkin Fellow and Marc Tetalman Memorial Award from the Society of Nuclear Medicine and Molecular Imaging, the Young Investigator Award from the Prostate Cancer Foundation, and the Wylie J. Dodds Research Award from the Society of Abdominal Radiology. To learn more about the Neuroendocrine Tumor Program at UCSF, click here: https://neuroendocrine.ucsf.edu/. CCF’s Luncheon with the Experts series features physicians and healthcare professionals, support group leaders, patients, and colleagues who are key opinion leaders in the neuroendocrine cancer community worldwide. This weekly series is presented via Facebook Live on Thursdays from 12 noon to 1 pm, Eastern Time. Join us for unique discussions on a wide variety of topics for everyone in the NET community! With special thanks to Ipsen Biopharmaceuticals, sponsor of the Luncheon with the Experts series. “At Ipsen, patients are the heart of our science.” Do you want to receive notifications every time CCF uploads a new video on YouTube? Be sure to CLICK LIKE, SUBSCRIBE, and HIT THE BELL.

Luncheon with the Experts: Mary A. Maluccio, MD, MPH, FACS

Cancer Immunotherapy 101 with Dr. E. John Wherry

Luncheon with the Experts: Pamela Kunz, MD

AI Is Creating A Rare Opportunity For Investors. How Jim Roppel Is Playing It. | Investing With IBD

Trump sta per invadere l’Iran? La diretta con Alessandro Orsini

Who REALLY Chooses Medicare Advantage vs Medigap (And Who Regrets It)

How to Start Coding | Programming for Beginners | Learn Coding | Intellipaat

What are some of the key issues facing Australia? - World Questions podcast, BBC World Service

Trump è disperato. La diretta con Alessandro Orsini

What do tech pioneers think about the AI revolution? - The Engineers, BBC World Service

TMS vs. Ketamine: Which One Is Better?

Obligations de TotalEnergies : audition de Jean-Marc Jancovici

Stoke Space CEO Andy Lapsa - Fully Reusable Rockets - NSF Live

Music Theory Masterclass 1: Drilling the Basics

What You Need To Know About Hell | #Jahannam Webinar by Dr. Omar Suleiman

Surgery for Neuroendocrine Tumors

TAKE ACTION: The war changes the market, the banks' turnaround, and the investment winners

They Had No Idea What Was About To Happen Today

Ketamine vs ECT for depression: what studies don't tell you - Dr. Kaveh LIVE

